Iron Acetate

Iron acetate is an inorganic iron salt formed from the reaction of iron ions with acetate anions, existing primarily as ferrous acetate (Fe(CH3COO)2) or ferric acetate (Fe(CH3COO)3). Unlike established iron supplements such as ferrous sulfate or ferrous bisglycinate, iron acetate lacks documented clinical evidence supporting its use as a dietary or therapeutic supplement in humans.

Origin & History

Iron acetate is a synthetic iron salt compound with molecular formula C₄H₆O₄Fe (iron(II) form) or more complex trinuclear structures for iron(III) variants, manufactured through chemical synthesis by treating iron sources with acetic acid or acetate salts. It exists in multiple oxidation states: iron(II) acetate appears as a white to light brown powder sensitive to air and moisture, while iron(III) acetate forms a brownish-red solid.

Historical & Cultural Context

No information regarding historical use in traditional medicine systems is present in the provided research. The sources focus exclusively on modern chemical and industrial applications without documenting any traditional or cultural therapeutic uses.

Health Benefits

• No clinical health benefits documented - The provided research contains no peer-reviewed clinical trials or therapeutic applications
• Industrial applications only - Current evidence limited to material synthesis and catalysis uses
• No biomedical efficacy data - Absence of RCTs, meta-analyses, or human subject studies
• No traditional medicine use recorded - Research lacks historical therapeutic applications
• Further clinical research needed - Current data insufficient to support health claims

How It Works

Iron acetate, when dissociated in aqueous solution, releases free iron ions (Fe2+ or Fe3+) that theoretically could participate in biological iron pathways, including binding to transferrin for transport and incorporation into hemoglobin and myoglobin via heme biosynthesis. Fe2+ ions interact with divalent metal transporter 1 (DMT1) in intestinal enterocytes for absorption, while Fe3+ requires reduction by duodenal cytochrome B (DcytB) prior to uptake. However, no pharmacokinetic or bioavailability studies in humans have been conducted to confirm these mechanisms apply to iron acetate specifically.

Scientific Research

The research dossier contains no peer-reviewed clinical trials, randomized controlled trials (RCTs), meta-analyses, or PubMed PMIDs evaluating iron acetate as a therapeutic agent in human subjects. The available sources focus exclusively on chemical properties and industrial applications rather than clinical efficacy or safety studies.

Clinical Summary

As of current available evidence, there are no peer-reviewed randomized controlled trials (RCTs), meta-analyses, or observational clinical studies evaluating iron acetate as a dietary supplement or therapeutic agent in human populations. The compound appears predominantly in materials science and chemistry literature, with applications in catalysis, textile dyeing, and nanoparticle synthesis. No studies have quantified its oral bioavailability, therapeutic dosing, or efficacy for treating iron deficiency anemia compared to established iron salts. The absence of clinical data means no evidence-based recommendations for supplemental use can be made.

Nutritional Profile

Iron acetate (Fe(CH₃COO)₂ or Fe(CH₃COO)₃, ferrous/ferric acetate) is an iron-organic acid salt, not a dietary supplement or food-grade mineral. Iron content varies by form: ferrous acetate (~32% Fe by molecular weight), ferric acetate (~21-24% Fe). It is NOT recognized as a safe nutritional iron source — pharmaceutical/food-grade iron supplements use ferrous sulfate (~20% elemental Fe), ferrous gluconate (~12% Fe), or ferrous bisglycinate (~20% Fe with superior bioavailability). Iron acetate lacks GRAS status, has no established RDA contribution pathway, and no bioavailability data exists for oral human consumption. It contains no vitamins, fiber, protein, or beneficial bioactive compounds. The acetate ligand offers negligible caloric or nutritional value. WARNING: Industrial-grade iron acetate may contain heavy metal contaminants and is intended for mordanting textiles, catalysis, and material science — not ingestion.

Preparation & Dosage

No clinically studied dosage ranges for iron acetate in human therapeutic applications are documented in the provided research. The sources reference only industrial and research applications without establishing standardized dosing protocols for medical use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Iron acetate itself is not recommended for supplementation, but if one seeks iron mineral synergies using food-grade iron sources instead: Vitamin C (ascorbic acid, 200-500 mg) dramatically enhances non-heme iron absorption by reducing Fe³⁺ to Fe²⁺ in the gut and chelating iron to maintain solubility, increasing uptake 3-6 fold. Lactoferrin (100-200 mg) improves iron transport across intestinal epithelium via receptor-mediated endocytosis independent of DMT1 pathways. Vitamin A (retinol/beta-carotene, 700-900 mcg RAE) counteracts the inhibitory effects of phytates and polyphenols on iron absorption by forming a soluble iron-vitamin A complex. Copper (1-2 mg as copper bisglycinate) is essential as a cofactor for ceruloplasmin/hephaestin, which oxidize Fe²⁺ to Fe³⁺ for transferrin loading and systemic iron mobilization. Vitamin B12 (methylcobalamin, 500-1000 mcg) works alongside iron in erythropoiesis, preventing concurrent deficiency-driven anemia.

Safety & Interactions

Iron acetate has no established safety profile, tolerable upper intake level, or documented adverse event data from human clinical use. Theoretically, excessive free iron intake from any source can cause gastrointestinal irritation, nausea, constipation, and at toxic doses, oxidative damage via Fenton chemistry generating hydroxyl radicals. Iron salts broadly interact with medications including fluoroquinolone and tetracycline antibiotics, levothyroxine, and levodopa, reducing their absorption when co-administered. Pregnant individuals should avoid uncharacterized iron compounds and consult a physician, as iron overload carries teratogenic risk and only well-studied forms are recommended in pregnancy.